Synergistic activity of the Src family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress

Scott Kopetz, Donald P. Lesslie, Nikolas A. Dallas, Serk I. Park, Marjorie Johnson, Nila U. Parikh, Michael P. Kim, James L. Abbruzzese, Lee M. Ellis, Joya Chandra, Gary E. Gallick

Research output: Contribution to journalArticlepeer-review

118 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Synergistic activity of the Src family kinase inhibitor dasatinib and oxaliplatin in colon carcinoma cells is mediated by oxidative stress'. Together they form a unique fingerprint.

Medicine & Life Sciences